Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6541)
All Articles published online
|
Oct 14, 2012 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT. Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol 2012; 18(38): 5442-5453 [PMID: 23082062 DOI: 10.3748/wjg.v18.i38.5442] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i38/5442.htm |
| Number | Citing Articles |
| 1 |
Lihui Zhu, Rongrong Liao, Jiwen Huang, Huaxiang Yan, Changfeng Xiao, Yunzhou Yang, Huiying Wang, Changsuo Yang. The miR-216/miR-217 Cluster Regulates Lipid Metabolism in Laying Hens With Fatty Liver Syndrome via PPAR/SREBP Signaling Pathway. Frontiers in Veterinary Science 2022; 9 doi: 10.3389/fvets.2022.913841
|
| 2 |
Fang Deng, Jing Mu, Chiwen Qu, Fang Yang, Xing Liu, Xiaomin Zeng, Xiaoning Peng. A Novel Prognostic Model of Endometrial Carcinoma Based on Clinical Variables and Oncogenomic Gene Signature. Frontiers in Molecular Biosciences 2021; 7 doi: 10.3389/fmolb.2020.587822
|
| 3 |
Wenxiu Jiang, Lili Wang, Yajuan Zhang, Hongliang Li. <p>Circ-ATP5H Induces Hepatitis B Virus Replication and Expression by Regulating miR-138-5p/<em>TNFAIP3</em> Axis</p>. Cancer Management and Research 2020; : 11031 doi: 10.2147/CMAR.S272983
|
| 4 |
Yan-Yan Jia, Jin-Yi Zhao, Bing-Ling Li, Kai Gao, Ying Song, Mei-You Liu, Xiao-Juan Yang, Yan Xue, Ai-Dong Wen, Lei Shi. miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth. Oncotarget 2016; 7(23): 35257 doi: 10.18632/oncotarget.9135
|
| 5 |
Hongmin Guo, Ting Li, Xinhui Sun. LncRNA HOTAIRM1, miR-433-5p and PIK3CD function as a ceRNA network to exacerbate the development of PCOS. Journal of Ovarian Research 2021; 14(1) doi: 10.1186/s13048-020-00742-4
|
| 6 |
Mehrdad Asadi, Ali Zolfi-Gol, Arash Mosarrezaii, Shiva Mehran, Zafar Gholinejad. Omnipresence MicroRNA-483: A comprehensive organ by organ literature review. Human Gene 2023; 37: 201195 doi: 10.1016/j.humgen.2023.201195
|
| 7 |
Junwei Shao, Jun Cao, Yong Liu, Hongliang Mei, Yang Zhang, Weitian Xu. Retracted: MicroRNA‐519a promotes proliferation and inhibits apoptosis of hepatocellular carcinoma cells by targeting FOXF2. FEBS Open Bio 2015; 5(1): 893 doi: 10.1016/j.fob.2015.10.009
|
| 8 |
Hao-Kang Li, Ru-Tsun Mai, Hsien-Da Huang, Chih-Hung Chou, Yi-An Chang, Yao-Wen Chang, Li-Ru You, Chun-Ming Chen, Yan-Hwa Wu Lee. DDX3 Represses Stemness by Epigenetically Modulating Tumor-suppressive miRNAs in Hepatocellular Carcinoma. Scientific Reports 2016; 6(1) doi: 10.1038/srep28637
|
| 9 |
Zhihong Yang, Hiroyuki Tsuchiya, Yuxia Zhang, M. Elizabeth Hartnett, Li Wang. MicroRNA-433 Inhibits Liver Cancer Cell Migration by Repressing the Protein Expression and Function of cAMP Response Element-binding Protein. Journal of Biological Chemistry 2013; 288(40): 28893 doi: 10.1074/jbc.M113.502682
|
| 10 |
Jun Li, Jingshun Gu, Juntong Wang, Aiwu You, Yuyan Zhang, Guomin Rao, Shuang Li, Xuehua Ge, Kun Zhang, Dongchun Wang. MicroRNA‐433‐3p enhances chemosensitivity of glioma to cisplatin by downregulating NR5A2. Brain and Behavior 2022; 12(12) doi: 10.1002/brb3.2632
|
| 11 |
Kurt Sartorius, Julia Makarova, Benn Sartorius, Ping An, Cheryl Winkler, Anil Chuturgoon, Anna Kramvis. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019; 8(12): 1504 doi: 10.3390/cells8121504
|
| 12 |
Kurt Sartorius, Leo Swadling, Ping An, Julia Makarova, Cheryl Winkler, Anil Chuturgoon, Anna Kramvis. The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways. Viruses 2020; 12(7): 746 doi: 10.3390/v12070746
|
| 13 |
Haowei He, Linhui Wang, Wenquan Zhou, Zhengyu Zhang, Longxin Wang, Song Xu, Dong Wang, Jie Dong, Chaopeng Tang, Hao Tang, Xiaoming Yi, Jingping Ge, Kandiah Jeyaseelan. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. PLOS ONE 2015; 10(5): e0125672 doi: 10.1371/journal.pone.0125672
|
| 14 |
Wei Liu, Xianzhao Zheng, Jie Wang, Quanli He, Junmin Li, Zengzeng Zhang, Hongchun Liu. MicroRNA-138 Regulates T-Cell Function by Targeting PD-1 in Patients with Hepatitis B Virus–Related Liver Diseases. Laboratory Medicine 2021; 52(5): 439 doi: 10.1093/labmed/lmaa110
|
| 15 |
Dóra Géczi, Bálint Nagy, Melinda Szilágyi, András Penyige, Álmos Klekner, Adrienn Jenei, József Virga, Zsuzsanna Birkó. Analysis of Circulating miRNA Profile in Plasma Samples of Glioblastoma Patients. International Journal of Molecular Sciences 2021; 22(10): 5058 doi: 10.3390/ijms22105058
|
| 16 |
Xiaoming Dai, Ruixue Huang, Sai Hu, Yao Zhou, Xiaoya Sun, Pucheng Gui, Zijian Yu, Pingkun Zhou. A novel miR-0308-3p revealed by miRNA-seq of HBV-positive hepatocellular carcinoma suppresses cell proliferation and promotes G1/S arrest by targeting double CDK6/Cyclin D1 genes. Cell & Bioscience 2020; 10(1) doi: 10.1186/s13578-020-00382-7
|
| 17 |
Hao Zhang, Chao Yu, Meiyuan Chen, Zhu Li, Se Tian, Jianxin Jiang, Chengyi Sun. miR-522 contributes to cell proliferation of hepatocellular carcinoma by targeting DKK1 and SFRP2. Tumor Biology 2016; 37(8): 11321 doi: 10.1007/s13277-016-4995-0
|
| 18 |
Jie Shen, Hyeon-soo Park, Yong-mei Xia, Gon-sup Kim, Steve W. Cui. The polysaccharides from fermented Ganoderma lucidum mycelia induced miRNAs regulation in suppressed HepG2 cells. Carbohydrate Polymers 2014; 103: 319 doi: 10.1016/j.carbpol.2013.12.044
|
| 19 |
A.V. Smirnova, V.N. Sukhorukov, V.P. Karagodin, A.N. Orekhov. Epigenetic factors in atherogenesis: microRNA. Biomeditsinskaya Khimiya 2016; 62(2): 134 doi: 10.18097/PBMC20166202134
|
| 20 |
Yan Du, Xue Han, Rui Pu, Jiaxin Xie, Yuwei Zhang, Guangwen Cao. Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk. Frontiers of Medicine 2014; 8(2): 217 doi: 10.1007/s11684-014-0326-2
|
| 21 |
Yanqiong Zhang, Xiaodong Guo, Zhiwei Li, Boan Li, Zhiyan Li, Ruisheng Li, Qiuyan Guo, Lu Xiong, Lingxiang Yu, Jingmin Zhao, Na Lin. A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma. RNA Biology 2015; 12(6): 643 doi: 10.1080/15476286.2015.1022702
|
| 22 |
Shu-qin Zhang, Zhe Yang, Xiao-li Cai, Man Zhao, Ming-ming Sun, Jiong Li, Guo-xing Feng, Jin-yan Feng, Li-hong Ye, Jun-qi Niu, Xiao-dong Zhang. miR-511 promotes the proliferation of human hepatoma cells by targeting the 3′UTR of B cell translocation gene 1 (BTG1) mRNA. Acta Pharmacologica Sinica 2017; 38(8): 1161 doi: 10.1038/aps.2017.62
|
| 23 |
Shupeng Sun, Xiuyu Wang, Xinnv Xu, Hui Di, Jixiang Du, Bin Xu, Qiong Wang, Jinhuan Wang. MiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human glioma. Oncotarget 2017; 8(3): 5057 doi: 10.18632/oncotarget.13789
|
| 24 |
Xiong‑Wei Cui, Zhi‑Ling Qian, Cong Li, Shi‑Chang Cui. Identification of miRNA and mRNA expression profiles by PCR microarray in hepatitis B virus‑associated hepatocellular carcinoma. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9516
|
| 25 |
Yingbin Hu, Jingshi Liu, Bonian Jiang, Juying Chen, Zhongpin Fu, Fei Bai, Jiarui Jiang, Ziyuan Tang. MiR-199a-5p Loss Up-Regulated DDR1 Aggravated Colorectal Cancer by Activating Epithelial-to-Mesenchymal Transition Related Signaling. Digestive Diseases and Sciences 2014; 59(9): 2163 doi: 10.1007/s10620-014-3136-0
|
| 26 |
Xiao Yang, Wangjie Jiang, Xiangxu Kong, Xiao Zhou, Deming Zhu, Lianbao Kong. Genistein Restricts the Epithelial Mesenchymal Transformation (EMT) and Stemness of Hepatocellular Carcinoma via Upregulating miR-1275 to Inhibit the EIF5A2/PI3K/Akt Pathway. Biology 2022; 11(10): 1383 doi: 10.3390/biology11101383
|
| 27 |
Felice Pepe, Rosa Visone, Angelo Veronese. The Glucose-Regulated MiR-483-3p Influences Key Signaling Pathways in Cancer. Cancers 2018; 10(6): 181 doi: 10.3390/cancers10060181
|
| 28 |
Si-nan Sun, Shuang Hu, Yu-ping Shang, Liang-yun Li, Hong Zhou, Jia-si Chen, Jun-fa Yang, Jun Li, Qiang Huang, Chuan-pu Shen, Tao Xu. Relevance function of microRNA-708 in the pathogenesis of cancer. Cellular Signalling 2019; 63: 109390 doi: 10.1016/j.cellsig.2019.109390
|
| 29 |
Heping Kan, Wenbin Guo, Yuqi Huang, Dingli Liu. Retracted: MicroRNA‐520g induces epithelial–mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7. FEBS Letters 2015; 589(1): 102 doi: 10.1016/j.febslet.2014.11.031
|
| 30 |
S. Fiorino, L. Bacchi-Reggiani, S. Sabbatani, F. Grizzi, L. di Tommaso, M. Masetti, A. Fornelli, A. Bondi, D. de Biase, M. Visani, A. Cuppini, E. Jovine, A. Pession. Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review. British Journal of Nutrition 2014; 112(11): 1751 doi: 10.1017/S0007114514002839
|
| 31 |
Krithi Irmady, Katherine A. Jackman, Victoria A. Padow, Neelam Shahani, Laura Andres Martin, Leandro Cerchietti, Klaus Unsicker, Costantino Iadecola, Barbara L. Hempstead. MiR-592 Regulates the Induction and Cell Death-Promoting Activity of p75NTRin Neuronal Ischemic Injury. The Journal of Neuroscience 2014; 34(9): 3419 doi: 10.1523/JNEUROSCI.1982-13.2014
|
| 32 |
Chunlin Jiang, Miao Yu, Xiaoyan Xie, Guangliang Huang, Yao Peng, Dong Ren, Manxia Lin, Baoxian Liu, Ming Liu, Wei Wang, Ming Kuang. miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma. Oncology Reports 2017; 38(4): 2351 doi: 10.3892/or.2017.5924
|
| 33 |
Dafeng Xu, Yachong Liu, Qiumeng Liu, Ganxun Li, Lu Zhang, Chengpeng Yu, Huifang Liang, Xiaoping Chen, Jinfang Zheng, Jia Song. N6-methyladenosine modification of circular RNA circASH2L suppresses growth and metastasis in hepatocellular carcinoma through regulating hsa-miR-525-3p/MTUS2 axis. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05745-z
|
| 34 |
Yaqin Zhang, Weihua Cao, Shiyu Wang, Lu Zhang, Xinxin Li, Ziyu Zhang, Yao Xie, Minghui Li. Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma. Virulence 2024; 15(1) doi: 10.1080/21505594.2024.2421231
|
| 35 |
Hui Liang, Yisong Xu, Qiang Zhang, Yu Yang, Yueyang Mou, Yingchun Gao, Rui Chen, Chao Chen, Penggao Dai. MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells. Artificial Cells, Nanomedicine, and Biotechnology 2019; 47(1): 725 doi: 10.1080/21691401.2019.1569530
|
| 36 |
Lianming Guo, Shasha Gao, Weiwei Sun, Yingying Wang, Jingjing Zhao. Elevated LINC01232 is associated with poor prognosis and HBV infection in hepatocellular carcinoma patients and contributes to tumor progression in vitro. Clinics and Research in Hepatology and Gastroenterology 2022; 46(3): 101813 doi: 10.1016/j.clinre.2021.101813
|
| 37 |
Yuanyuan Dong, Juan Long, Xingyong Luo, Gang Xie, Zhi‐Xiong Jim Xiao, Ying Tong. Targeting of ΔNp63α by miR‐522 promotes the migration of breast epithelial cells. FEBS Open Bio 2021; 11(2): 468 doi: 10.1002/2211-5463.13072
|
| 38 |
Shubao Zhang, Hongzhen Zhang, Jianxin Zhu, Xueguang Zhang, Yuguang Liu. MiR-522 contributes to cell proliferation of human glioblastoma cells by suppressing PHLPP1 expression. Biomedicine & Pharmacotherapy 2015; 70: 164 doi: 10.1016/j.biopha.2015.01.017
|
| 39 |
Ruiqing Peng, Jianlong Men, Rui Ma, Qian Wang, Yang Wang, Ying Sun, Jing Ren. miR-214 down-regulates ARL2 and suppresses growth and invasion of cervical cancer cells. Biochemical and Biophysical Research Communications 2017; 484(3): 623 doi: 10.1016/j.bbrc.2017.01.152
|
| 40 |
Li Lin, Xiaomao Yin, Xiumei Hu, Qian Wang, Lei Zheng. The impact of hepatitis B virus x protein and microRNAs in hepatocellular carcinoma: a comprehensive analysis. Tumor Biology 2014; 35(12): 11695 doi: 10.1007/s13277-014-2658-6
|
| 41 |
Nicholas J. Monteleone, Carol S. Lutz. miR-708-5p: a microRNA with emerging roles in cancer. Oncotarget 2017; 8(41): 71292 doi: 10.18632/oncotarget.19772
|
| 42 |
Bohan Zhang, Liang Huang, Jiangbo Tu, Tianming Wu. <p>Hypoxia-Induced Placenta-Specific microRNA (miR-512-3p) Promotes Hepatocellular Carcinoma Progression by Targeting Large Tumor Suppressor Kinase 2</p>. OncoTargets and Therapy 2020; : 6073 doi: 10.2147/OTT.S254612
|
| 43 |
Guangjun Li, Fang Yang, Hongwei Xu, Zhongyi Yue, Xiangjie Fang, Jingjing Liu. MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration. Biomedicine & Pharmacotherapy 2015; 73: 154 doi: 10.1016/j.biopha.2015.05.010
|
| 44 |
Jinjing Zhong, Rui Huang, Zhengzheng Su, Mengni Zhang, Miao Xu, Jing Gong, Ni Chen, Hao Zeng, Xueqin Chen, Qiao Zhou. Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α. Oncotarget 2017; 8(48): 83523 doi: 10.18632/oncotarget.18315
|
| 45 |
Hua Ye, Liping Pang, Qiong Wu, Yuzhen Zhu, Cancan Guo, Ying Deng, Xuebao Zheng. A critical role of mir-199a in the cell biological behaviors of colorectal cancer. Diagnostic Pathology 2015; 10(1) doi: 10.1186/s13000-015-0260-x
|
| 46 |
Li Wen, Cen Jiang, Ting-Jun Wan, Dong Wang, Di Yan, Gui-Yu Li, Yue Su, Xi-Yang Liu, Li-Jun Rong, Hua Ye, Bai-Xue Li, Quan-Sheng Feng, Juntra Karbwang. Biological Differentiation of Dampness‐Heat Syndromes in Chronic Hepatitis B: From Comparative MicroRNA Microarray Profiling to Biomarker Identification. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/7234893
|
| 47 |
Jin Song, Shan Luo, Shang-wei Li. miRNA-592 is downregulated and may target LHCGR in polycystic ovary syndrome patients. Reproductive Biology 2015; 15(4): 229 doi: 10.1016/j.repbio.2015.10.005
|
| 48 |
Asahiro Morishita, Hisakazu Iwama, Shintaro Fujihara, Teppei Sakamoto, Koji Fujita, Joji Tani, Hisaaki Miyoshi, Hirohito Yoneyama, Takashi Himoto, Tsutomu Masaki. MicroRNA profiles in various hepatocellular carcinoma cell lines. Oncology Letters 2016; 12(3): 1687 doi: 10.3892/ol.2016.4853
|
| 49 |
Kurt Sartorius, Ping An, Cheryl Winkler, Anil Chuturgoon, Xiaodong Li, Julia Makarova, Anna Kramvis. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.661204
|
| 50 |
Tianze Zhang, Yingying Hu, Jin Ju, Liangyu Hou, Zhange Li, Dan Xiao, Yongchao Li, Jianyu Yao, Chao Wang, Yong Zhang, Linyou Zhang. Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D. Scientific Reports 2016; 6(1) doi: 10.1038/srep19346
|
| 51 |
Feng Shuai, Bo Wang, Shuxiao Dong. miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(7): 1113 doi: 10.3727/096504018X15166199939341
|
| 52 |
Tanu Sharma, Ryan Hamilton, Chandi C Mandal. miR-214: a potential biomarker and therapeutic for different cancers. Future Oncology 2015; 11(2): 349 doi: 10.2217/fon.14.193
|
| 53 |
Yuanyuan Wang, Jingmei Cao, Shiyun Zhang, Lei Sun, Yi Nan, Hong Yao, Jian Fan, Li Ying Zhu, Lei Yu. MicroRNA-802 induces hepatitis B virus replication and replication through regulating SMARCE1 expression in hepatocellular carcinoma. Cell Death & Disease 2019; 10(10) doi: 10.1038/s41419-019-1999-x
|
| 54 |
Sandra Franco, Daniela Buccione, Raquel Pluvinet, Beatriz Mothe, Lidia Ruiz, Maria Nevot, Ana Jordan-Paiz, Laia Ramos, Susanna Aussó, Rosa M. Morillas, Lauro Sumoy, Miguel Angel Martinez, Cristina Tural. Large-scale screening of circulating microRNAs in individuals with HIV-1 mono-infections reveals specific liver damage signatures. Antiviral Research 2018; 155: 106 doi: 10.1016/j.antiviral.2018.05.008
|
| 55 |
Niraj M Shah, Stuart A Rushworth, Megan Y Murray, Kristian M Bowles, David J MacEwan. Understanding the role of NRF2-regulated miRNAs in human malignancies. Oncotarget 2013; 4(8): 1130 doi: 10.18632/oncotarget.1181
|
| 56 |
D Völler, J Reinders, G Meister, A-K Bosserhoff. Strong reduction of AGO2 expression in melanoma and cellular consequences. British Journal of Cancer 2013; 109(12): 3116 doi: 10.1038/bjc.2013.646
|
| 57 |
Sora Kim, Gwang Ha Kim, Su Jin Park, Chae Hwa Kwon, Hoseok I, Moon Won Lee, Bong Eun Lee. Exosomal MicroRNA Analyses in Esophageal Squamous Cell Carcinoma Cell Lines. Journal of Clinical Medicine 2022; 11(15): 4426 doi: 10.3390/jcm11154426
|
| 58 |
Zhi Xiong Chong, Swee Keong Yeap, Wan Yong Ho, Chee Mun Fang. Unveiling the tumour-regulatory roles of miR-1275 in cancer. Pathology - Research and Practice 2022; 230: 153745 doi: 10.1016/j.prp.2021.153745
|
| 59 |
S. Timmermans, F. Van Hauwermeiren, L. Puimège, L. Dejager, E. Van Wonterghem, V. Vanhooren, P. Mestdagh, C. Libert, R. E. Vandenbroucke. Determining differentially expressed miRNAs and validating miRNA—target relationships using the SPRET/Ei mouse strain. Mammalian Genome 2015; 26(1-2): 94 doi: 10.1007/s00335-014-9550-y
|
| 60 |
Xiao-chun Wang, Ying Ma, Pei-song Meng, Jia-long Han, Hai-yan Yu, Liang-jia Bi. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6. Oral Oncology 2015; 51(7): 674 doi: 10.1016/j.oraloncology.2015.04.010
|
| 61 |
Jason Lamontagne, Laura F Steel, Michael J Bouchard. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases. World Journal of Gastroenterology 2015; 21(24): 7375-7399 doi: 10.3748/wjg.v21.i24.7375
|
| 62 |
Sanjay Kumar, Lung-Wen Tsai, Pavan Kumar, Rajni Dubey, Deepika Gupta, Anjani Kumar Singh, Vishnu Swarup, Himanshu Narayan Singh. Genome-Wide Scanning of Potential Hotspots for Adenosine Methylation: A Potential Path to Neuronal Development. Life 2021; 11(11): 1185 doi: 10.3390/life11111185
|
| 63 |
Haritz Irizar, Maider Muñoz-Culla, Matías Sáenz-Cuesta, Iñaki Osorio-Querejeta, Lucía Sepúlveda, Tamara Castillo-Triviño, Alvaro Prada, Adolfo Lopez de Munain, Javier Olascoaga, David Otaegui. Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA – mRNA network analysis. BMC Genomics 2015; 16(1) doi: 10.1186/s12864-015-1396-5
|
| 64 |
Xiaopeng Dai, Wei Zhang, Hongfei Zhang, Shihui Sun, Hong Yu, Yan Guo, Zhihua Kou, Guangyu Zhao, Lanying Du, Shibo Jiang, Jianying Zhang, Junfeng Li, Yusen Zhou. Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1α. Nucleic Acids Research 2014; 42(10): 6578 doi: 10.1093/nar/gku260
|
| 65 |
Jinnan Yue, Dacheng Lv, Caiyun Wang, Ling Li, Qingnan Zhao, Hongzhuan Chen, Lu Xu. Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3. Oncogene 2018; 37(31): 4300 doi: 10.1038/s41388-018-0276-2
|
| 66 |
T Bertero, C Gastaldi, I Bourget-Ponzio, B Mari, G Meneguzzi, P Barbry, G Ponzio, R Rezzonico. CDC25A targeting by miR-483-3p decreases CCND–CDK4/6 assembly and contributes to cell cycle arrest. Cell Death & Differentiation 2013; 20(6): 800 doi: 10.1038/cdd.2013.5
|
| 67 |
Jun Yang, Tao Qin, Shanshan Liu, Hui Tang, Mengqing Liu, Qian Wang.
Interaction Analysis of
MIR-1275/IGF2BP1/IGF2BP3
with the Susceptibility to Hepatocellular Carcinoma
. Biomarkers in Medicine 2020; 14(4): 283 doi: 10.2217/bmm-2019-0332
|
| 68 |
Baixue Li, Yue Su, Ne Xiang, Bing Qin, Guiyu Li, Tingjun Wan, Xiyang Liu, Dong Wang, Cen Jiang, Li Wen, Quan‐Sheng Feng. Comparative serum microRNA array analysis of the spleen‐stomach dampness‐heat syndrome in different diseases: Chronic hepatitis B and chronic gastritis. The Anatomical Record 2021; 304(11): 2620 doi: 10.1002/ar.24690
|
| 69 |
Li Hong, Liu Ya-wei, Wang Hai, Zhou Qiang, Li Jun-jie, Annie Huang, Qi Song-tao, Lu Yun-tao. MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway. Journal of Neuro-Oncology 2016; 128(1): 35 doi: 10.1007/s11060-016-2095-z
|
| 70 |
Injie Omar Fawzy, Mohammed Tarif Hamza, Karim Adel Hosny, Gamal Esmat, Hend Mohamed El Tayebi, Ahmed Ihab Abdelaziz. miR‐1275: A single microRNA that targets the three IGF2‐mRNA‐binding proteins hindering tumor growth in hepatocellular carcinoma. FEBS Letters 2015; 589(17): 2257 doi: 10.1016/j.febslet.2015.06.038
|
| 71 |
Thomas BERTERO, Isabelle BOURGET-PONZIO, Alexandre Puissant, Agnès LOUBAT, Bernard Mari, Guerrino Meneguzzi, Patrick Auberger, Pascal Barbry, Gilles Ponzio, Roger REZZONICO. Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties. Cell Cycle 2013; 12(14): 2183 doi: 10.4161/cc.25330
|
| 72 |
Ming Zhang, Dequan Liu, Wenhui Li, Xiaoli Wu, Chang’e Gao, Xiangnan Li. Identification of featured biomarkers in breast cancer with microRNA microarray. Archives of Gynecology and Obstetrics 2016; 294(5): 1047 doi: 10.1007/s00404-016-4141-7
|
| 73 |
Cuiping Wang, Yang Sun, Huanwen Wu, Shuangni Yu, Li Zhang, Yunxiao Meng, Mingyang Liu, Haiyan Yang, Pingping Liu, Xinxin Mao, Zhaohui Lu, Jie Chen. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma. Tumor Biology 2015; 36(12): 9447 doi: 10.1007/s13277-015-3690-x
|
| 74 |
Bei Zhang, Siqi Han, Bing Feng, Xiaoyuan Chu, Longbang Chen, Rui Wang. Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma. Experimental & Molecular Medicine 2017; 49(2): e293 doi: 10.1038/emm.2016.177
|
| 75 |
Kendall R. Van Keuren‐Jensen, Ivana Malenica, Amanda L. Courtright, Layla T. Ghaffari, Alex P. Starr, Raghu P. Metpally, Taylor A. Beecroft, Elizabeth W.J. Carlson, Jeffrey A. Kiefer, Paul J. Pockros, Jorge Rakela. microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis C. Liver International 2016; 36(3): 334 doi: 10.1111/liv.12919
|
| 76 |
A. V. Smirnova, V. N. Sukhorukov, V. P. Karagodin, A. N. Orekhov. Epigenetic factors in atherogenesis: MicroRNA. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 2016; 10(3): 269 doi: 10.1134/S199075081603015X
|
| 77 |
Cailing Shi, Xudong Xu. MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2013; 67(5): 375 doi: 10.1016/j.biopha.2013.03.002
|
| 78 |
Ke-Qing Shi, Zhuo Lin, Xiang-Jian Chen, Mei Song, Yu-Qun Wang, Yi-Jing Cai, Nai-Bing Yang, Ming-Hua Zheng, Jin-Zhong Dong, Lei Zhang, Yong-Ping Chen. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. Oncotarget 2015; 6(28): 25093 doi: 10.18632/oncotarget.4437
|